Andrew G. Spencer
Nessuna posizione attualmente
Profilo
Andrew G.
Spencer worked as a Senior VP-Preclinical Research & Development at Millendo Therapeutics, Inc. from 2016 to 2020.
Prior to that, he was a Vice President-Pharmacology at Ardelyx, Inc. Dr. Spencer holds a doctorate degree from Michigan State University and an undergraduate degree from Hope College.
Precedenti posizioni note di Andrew G. Spencer
| Società | Posizione | Fine |
|---|---|---|
| MILLENDO THERAPEUTICS | Direttore Tecnico/Scientifico/R&S | 01/04/2020 |
| ARDELYX, INC. | Corporate Officer/Principal | - |
Formazione di Andrew G. Spencer
| Michigan State University | Doctorate Degree |
| Hope College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARDELYX, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
- Borsa valori
- Insiders
- Andrew G. Spencer
